The largest study to investigate the role of inflammatory biomarkers in hospitalized COVID-19 patients uncovers risk factors for worse health outcomes in those with diabetes.

In type 1 diabetes, new research identifies critical ways to improve blood sugar management across different demographic groups.

For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.

Only 1 in 10 people with diabetes in low- and middle-income countries are getting evidence-based, low-cost comprehensive care.

Lowering blood sugar levels and shedding weight can help combat diabetes complications, but researchers say this “one size fit all” approach ignores other risk factors.